Professional Documents
Culture Documents
UIP2612 - Topic 3 - Patents (DR Manique)
UIP2612 - Topic 3 - Patents (DR Manique)
Topic 3: Patents
Part 2
• Exclusions; Ownership; Rights;
• Dealing; Duration of protection;
Part 3
• Infringement; Enforcement
• Defences
LO COURSE LEARNING OUTCOMES
Lim Choong Huat & Ors v Syntlz Enterprise Sdn Bhd & Ors (Hamid
Sultan Abu Backer, JC (as he was then) stated that PA 83 permitted
the granting of a patent “only to encourage and develop new
technology.”
(ii) Social contract theory: A contract exists between the inventor and
society because the inventor agrees to disclose his invention to the public in
exchange for a limited monopoly to exploit the invention.
• (Ref for extra reading: Lim Heng Gee, ‘A Study of the Historial Development
of the Malaysian Patent System’, Perspectives on Intellectual Property, Vol
1, ‘The Prehistory and Development of Intellectual Property Systems’
(1997), Sweet & Maxwell, UK. )
2. Patent Law in Malaysia
• Product Patent refers to a physical entity. While a process refers to a method or use.
• Section 3 defines a “product” as anything which appears in a tangible form and includes any
apparatus, article, device, equipment, handicraft, implement, machine, substance and
composition. (Examples: chemical compound, a pharmaceutical’s active ingredient or an
object)
• Section 3 defines a “process” as including an art or a method. (Example: an activity
performed upon some material product to achieve a certain result.)
• Sanofi-Aventis (M) Sdn Bhd & Anor v Fresenius Kabi (M) Sdn Bhd & Anor [2012] 4 CLJ 532
What is Non Patentable?
Section 13. Non-patentable inventions
(1) Notwithstanding the fact that they may be inventions within the meaning of
section 12, the following shall not be patentable:
(a) discoveries, scientific theories and mathematical methods;
(b) plant or animal varieties or essentially biological processes for the production
of plants or animals, other than man-made living micro-organisms, micro-
biological processes and the products of such micro-organism processes;
(c) schemes, rules or methods for doing business, performing purely mental
acts or playing games;
(d) methods for the treatment of the human or animal body by surgery or
therapy, and diagnostic methods practised on the human or animal
body: Provided that this paragraph shall not apply to products used in any such
methods.
* The above is excluded as they do not constitute an “idea” but are either things which
already exists in nature or are scientific experiments and also they are not problems arising
in the field of technology.
Contrary to Public Order or Morality
(1) Subject to any direction of the Minister, where an application for a patent is
filed or is deemed to have been filed at the Patent Registration Office and it
appears to the Registrar that the application contains information the
publication of which might be prejudicial to the interest or security of the
nation, he may issue directions prohibiting or restricting the publication of
that information or its communication whether generally or to a particular
person or class of persons.
(3) Where directions issued by the Registrar under subsection (1) are in
force in respect of an application, the application may proceed to the
stage where it is in order for the grant of a patent but no patent shall be
granted in pursuance of such application.
4. Requirements for Patentability/Qualifications
• The inventor must disclose the invention in order for there to be an increase to the pool
of knowledge. This indicates that the invention is new as otherwise there is nothing that
he has contributed / added to the existing pool of knowledge. Thus the “newness” is
statutorily embodied in section 11 in the form of the novelty requirement. Pursuant to
section 14 a invention is new if it is not anticipated by the prior art.
• SKB Shutters Industries Sdn Bhd & Anor Manufacturing Sdn Bhd V Seng Kong Shutter
Industries Sdn Bhd & Anor [2015] 6 AMR 358
Section 14: Novelty
• If the art is one having a highly developed technology, the notional skilled
reader to whom the document is addressed may not be a single person but
a team . . . When the prior inventor’s publication and the patentee’s claim
have respectively been construed by the court in the light of all properly
admissible evidence as to technical matters, the meaning of words and
expressions used in the art and so forth, the question whether the
patentee’s claim is new . . . falls to be decided as a question of fact.
• If the prior inventor’s publication contains a clear description of, or clear instructions to
do or make, something that would infringe the patentee’s claim is carried out after the
grant of the patentee’s patent, the patentee’s claim will have been shown to lack the
necessary novelty, that is to say, it will have been anticipated. The prior inventor,
however, and the patentee may have approached the same device from different starting
points and may for this reason, or it may be for other reasons, have so described their
devices that it cannot be immediately discerned from a reading of the language which
they have respectively used that they have discovered in truth the same device; but if
carrying out the directions contained in the prior inventor’s publication will inevitably
result in something being made or done which, if the patentee’s patent were valid,
would constitute an infringement of the patentee’s claim, this circumstance
demonstrates that the patentee’s claim has in fact been anticipated.
• If, on the other hand, the prior publication contains a direction which is capable of being
carried out in a manner which would infringe the patentee’s claim, but would be at least
as likely to be carried out in a way which would not do so, the patentee’s claim will not
have been anticipated, although it may fail on the ground of obviousness.
• To anticipate the patentee’s claim the prior publication must contain
clear and unmistakable directions to do what the patentee claims to
have invented. A signpost, however clear, upon the road to the
patentee’s invention will not suffice. The prior inventor must be
clearly shown to have planted his flag at the precise destination
before the patentees.
Sungei Kahan Palm Oil Sdn Bhd & Anor v YKL Engineering Sdn Bhd [2020] MLJU
953
b) Information given in Confidence?
It still falls within prior art (PA ‘83) provides some redress.
c)Priority date: This is the date that is usually set aside as some sort of
a cut off point at which an invention is to be assessed against the prior
art to determine novelty.
• Statutory exclusions from prior art…
Some disclosures are excluded- the PA ‘83 excludes some types of
information that have been disclosed to the public from being considered
part of the prior art for assessing novelty. These are provided in section
14(3)…(4).
• Medical use exception/Section 13(1)(d) (The mere fact that the product is not novel
will not destroy the novelty of the use of that product for a method of medical
treatment. This provides and incentive for the Pharmaceutical companies to develop
new methods of using a known substance for medical treatment)
• The PA ‘83 provides an exception for the patentability of a known substance or composition for
the patentability of a known substance or composition for use a method of treatment by surgery,
therapy or diagnosis in the situation provide in section 14(4).
• This means where a substance or composition is part of the prior art but a new medicinal or
veterinary use of that product is found, the mere fact that the product is not novel will not
destroy the novelty of the use of that product for a method of medical treatment.
• This exception to section 13(1)(d) is a product claim which is restricted to the substance or
composition when presented or packaged for the specific use. Ex: presented as “for use of
medicament”/ “use of as an anti-bacteria” / “for curing disease Y”.
• This is also called the “Swiss type” claim. A claim in patent law is a format previously used to
protect the use of a known substance for the manufacture of a medicament for a new therapeutic
application, often in the context of pharmaceutical patents, with a structure like “Use of [known
substance] for the treatment of [new indication].”
• The novelty lies in the new pharmaceutical use even though the substance or composition is
known.
• John Wyeth & Brother Ltd’s Application [1985] RPC 545
• Held: that section 2(6) of the UK Patent Act 1977 encompassed second and
subsequent medical uses which were drafted in the Swiss style format. The
Swiss style claim in the case was “the use of guanidine in the preparation of
an anti-diarrhoeal agent for treating or preventing diarrhoea. Prior to that,
guanidines were known pharmaceuticals used to lower blood pressure. The
claim was allowed by the English Patent Court. The case also held that Swiss
Type Claims were process claims since they were in reality a claim to the
method of manufacture.
• Merck Sharp & Dohme Corp & Anor V Hovid Bhd [ [2017] AMEJ 0017, HC
• Held that the Malaysian Guidelines for Patent Examination allows Swiss type claims in
the form of “Use of a substance or composition X for the manufacture of a medicament
for therapeutic application Z” for second and subsequent medical use which are new and
inventive.
• Reference cases
• Premier Products Co Ltd & Anor v Zamrud Fibre Industries (M) Sdn
Bhd [1994] 3 AMR 2324/ [1994] 4 CLJ 1042
• Heveafoam Asia Sdn Bhd v PF (Teknologi) Sdn Bhd [2001] 2 MLJ 660
Question: What is an Inventive Step?
Section 15: Inventive step.
An invention shall be considered as involving an inventive step if, having
regard to any matter which forms part of the prior art under paragraph
14(2)(a), such inventive step would not have been obvious to a person
having ordinary skill in the art.
• The “person having ordinary skill in the art” is a hypothetical person created by
the law. It is not any specific person.
The test for obviousness is given in Windsurfing International Inc v Tabur Marine
(Great Britain) Ltd [1985] RPC 59 (CA).
• Sanofi –Aventis (M) Sdn Bhd & Anor v Fresenius Kabi (M) Sdn Bhd &
Anor [2012] 4 CLJ 532
• See Hau Global Sdn Bhd v Mah Sing Plastics Industries Sdn Bhd [2018]
1 MLJ 213
Question: What is Industrial Application?
The Registrar in the exercise of his powers shall have the right to refuse to grant a
patent for products or processes scheduled under regulations made by the Minister
under this Act where it appears to the Registrar that the granting of such a patent
would be prejudicial to the interest or security of the nation.
Part 2
• Exclusions; Ownership; Rights;
• Dealing; Duration of protection;
• Infringement; Enforcement
1. Ownership Rights/ Rights to a Patent
Section 18. Right to a patent
(1) Any person may make an application for a patent either alone or jointly with
another.
(2) Subject to section 19, the rights to a patent shall belong to the inventor.
(3) Where two or more persons have jointly made an invention, the rights to a
patent shall belong to them jointly.
(4) If two or more persons have separately and independently made the same
invention, and each of them has made an application for a patent, the right to a
patent for that invention shall belong to the person whose application has the
earliest priority date.
Section 22. Joint owners
Where the right to obtain a patent is owned jointly, the patent may
only be applied for jointly by all the joint owners.
(1) In the absence of any provisions to the contrary in any contract of employment or for the
execution of work, the rights to a patent for an invention made in the performance of such
contract of employment or in the execution of such work shall be deemed to accrue to the
employer, or the person who commissioned the work, as the case may be:
Provided that where the invention acquires an economic value much greater than the parties could
reasonably have foreseen at the time of concluding the contract of employment or for the
execution of work, as the case may be, the inventor shall be entitled to equitable remuneration
which may be fixed by the Court in the absence of agreement between the parties.
(2) Where an employee whose contract of employment does not require him to engage in any
inventive activity makes, in the field of activities of his employer, an invention using data or means
placed at his disposal by his employer, the right to the patent for such invention shall be deemed to
accrue to the employer in the absence or any provision to the contrary in the contract of
employment:
Provided that the employee shall be entitled to equitable remuneration which, in the absence of
agreement between the parties, may be fixed by the Court taking into account his emoluments, the
economic value of the invention and any benefit derived from it by the employer.
(3) The rights conferred on the inventor under subsections (1) and (2) shall not be restricted by
contract.
2. Patent Application
• Patents Regulations 1986 and shall come into force on the 1st October
1986.
• Regulation 5. Application for Grant of Patent.
(1) An application shall contain‐
(a) a request for the grant of a patent;
(b) a description;
(c) a claim or claims;
(d) a drawing or drawings, where required; and
(e) an abstract.
(2) The application shall be filed at the Patent Registration Office.
• Regulation 5A. Filing of an international application.
(1) An international application shall be filed in three copies.
(2) Where an international application is filed in less than three copies,
the Patent Registration Office shall prepare the additional copies
required and the applicant shall pay to the Patent Registration
Office the prescribed fees for preparing such additional copies
Section 30.
Substantive examination and modified substantive examination. (1) Where a
request for substantive examination has been filed under subsection 29A(1),
the Registrar shall refer the application to an Examiner who shall ‐ (a)
determine whether the application complies with those requirements of this
Act and the regulations made under this Act which are designated by such
regulations as substantive requirements for the purposes of this Act; and (b)
report his determination to the Registrar.
Regulation 27C. Substantive examination.
(1) The requirements of sections 13,14,15 and 16, Part V, and sections
26, 26A, 26B, and 27 of the Act and regulations 7 (2), 12 to 17, 21 and
50 shall be substantive requirements for the purposes of section 30 (1)
of the Act.
• These are:
Section 13: Non-patentable inventions,
Section 14: Novelty,
Section 15: Inventive step,
Section 16: Industrial application,
Part V (sections 18–22): Rights to a patent,
Section 26: Unity of invention,
Section 26A: Amendment of application,
Section 26B: Division of application
Section 27: Right of priority
Reg 7(2): Title of invention,
Reg 12: Description,
Reg 13: Claims,
Reg 14: Dependent claims,
Reg 15: Drawings,
Reg 16: Abstract,
Reg 17: Measures, terminology and signs,
Reg 21: Declaration claiming priority, and
Reg 50: Signatures by partnerships, companies and associations.
Section 29A. Request for substantive examination or modified
substantive examination.
(1) If an application for a patent has been examined under section 29
and is not withdrawn or refused, the applicant shall file, within the
prescribed period, a request for a substantive examination of the
application.
Reg 27. Request for substantive examination.
(1) A request for a substantive examination shall be made to the
Registrar on Form 5 together with the payment of the prescribed fee
within eighteen months from the filing date of the application.
5. Public Inspection
S 34. Public inspection.
(1) The Registrar shall make available for public inspection after eighteen months from the priority date or filing date of a
patent
application and upon payment of the prescribed fee—
(a) the name, address and description of the applicant and the
name and address of his agent, if any;
(b) the application number;
(c) the filing date of the application and, if priority is claimed, the priority date, the number of the earlier application and the
name of the State in which the earlier application was filed or where the earlier application is a regional or an international
application, the name of the country or countries for which and the office at which it was filed;
(d) the particulars of the application including the description, claim or claims, drawing or drawings, if any, and the abstract
and any amendments to the application, if any;
and
(e) any change in ownership of the application and any reference to a licence contract appearing in the file relating to the
application.
6. Grant of Patent
Section 31 (2): Where the Registrar is satisfied that the application complies
with sections 23, 29 and 30, he shall grant the patent and shall
forthwith—
(a) issue to the applicant a certificate of grant of the patent and a copy of the
patent together with a copy of the Examiner’s final report; and
(b) record the patent in the Register.
(3) As soon as possible thereafter the Registrar shall—
(a) cause to be published in the Gazette a reference to the grant
of the patent; and
(b) make available to the public, on payment of the prescribed
fee, copies of the patent.
Duration of validity
S 35. Duration of patent.
(1) Subject to subsections (1B) and (1C), the duration of a patent shall be
twenty years from the filing date of the application.
(1A) Without prejudice to subsection (1) and subject to the other provisions
of this Act, a patent shall be deemed to be granted and shall take effect on
the date the certificate of grant of the
patent is issued.
(2) Where a patentee intends at the expiration of the second year from the
date of grant of the patent to keep the same in force he shall, twelve months
before the date of expiration of the second and each succeeding year during
the term of the patent, pay the prescribed annual fee:
Provided, however, that a period of grace of six months shall be allowed
after the date of such expiration, upon payment of such surcharge as may be
prescribed.
(3) If the prescribed annual fee is not paid in accordance with subsection (2),
the patent shall lapse, and a notice of the lapsing of the patent for non-
payment of any annual fee shall be published in the Gazette.
Rights of a Patent Owner
Section 36. Rights of owner of patent.
(1) Subject and without prejudice to the other provisions of this
Part, the owner of a patent shall have the following exclusive
rights in relation to the patent:
(a) to exploit the patented invention;
(b) to assign or transmit the patent;
(c) to conclude licence contract
(2) No person shall do any of the acts referred to in subsection (1)
without the consent of the owner of the patent.
(3) For the purposes of this Part, “exploitation” of a patented invention
means any of the following acts in relation to a patent:
(a) when the patent has been granted in respect of a product:
(i) making, importing, offering for sale, selling or using the product;
(ii) stocking such product for the purpose of offering for sale, selling or
using;
(b) when the patent has been granted in respect of a process:
(i) using the process;
(ii) doing any of the acts referred to in paragraph (a), in respect of a
product obtained directly by means of the process.
Section 40. Joint ownership of patent applications or patents.
• In the absence of any agreement to the contrary between the parties,
joint owners of a patent application or patent may, separately, assign
or transmit their rights in the patent application or patent, exploit the
patented invention and take action against any person exploiting the
patented invention without their consent, but may only jointly
withdraw the patent application, surrender the patent or conclude a
licence contract.
Section 39. Assignment and transmission of patent applications and patents.
The leading case for the pith and marrow construction approach is
Rodi & Wienenberger AG v Henry Showell Ltd [1969] 12 RPC 367 (HL).
Lord Upjohn:
In considering the claim the court must ascertain what are the essential integers of
the claim; this remains a question of construction and no general principles can be
laid down . . . Secondly, the essential integers having been ascertained, the
infringing article must be considered. To constitute infringement the article must
take each and every one of the essential integers of the claim . . . Furthermore,
where the invention, as in this case, resides in a new combination of known
integers but also merely in a new arrangement and interaction of ordinary working
parts it is not sufficient to show that the same result is reached; the working parts
must act on one another in the way claimed in the claim of this patent. This is well
illustrated by Birmingham Sound Reproducers Ltd v Collaro Ltd . . .
Rodi & Wienenberger AG v Henry Showell Ltd was accepted in Lim
Choong Huat v Syntlz Enterprise Sdn Bhd [2010] 1 CLJ 860 (HC). •
Hamid Sultan Abu Backer JC:
In essence, the infringement tests require one to consider three
factors, namely: (i) determine the “essential” integers (inessential
integers is not important because there may be mechanical equivalent)
of the plaintiff’s patent; (ii) once the “essential” integer is determined,
one must then consider whether “each” and “every” “essential” integer
is taken by the defendants; (iii) determine whether each of the
defendants’ “works” the “same way” as claimed by the plaintiff in their
Patent.
• Purposive Construction
Catnic Components Ltd v Hill and Smith Ltd [1982] RPC 183 (HL). • Lord
Diplock:
“A patent specification should be given a purposive construction rather than
a purely literal one derived from applying to it the kind of meticulous verbal
analysis in which lawyers are too often tempted by their training to indulge.
The question in each case is: whether persons with practical knowledge and
experience of the kind of work in which the invention was intended to be
used, would understand that strict compliance with a particular descriptive
word or phrase appearing in a claim was intended by the patentee to be an
essential requirement of the invention so that any variant would fall outside
the monopoly claimed, even though it could have no material effect upon
the way the invention worked.”
Declaration of Non-Infringement
(2) Without prejudice to section 58A, the rights under the patent shall not
extend to acts in respect of products which have been put on the market—
(i) by the owner of the patent;
(ii) by a person having the right referred to in section 38;
(iii) by a person having the right referred to in section 43;
(iv) by the beneficiary of a compulsory licence within the meaning of
section 48.
(3) The rights under the patent shall not extend to the use of the
patented invention on any foreign vessel, aircraft, spacecraft or land
vehicle temporarily in Malaysia.
(4) The rights under the patent shall be limited in duration as provided
for in section 35.
(5) The rights under the patent shall be limited by section 35A by the
provisions on compulsory licences as provided in sections
51 and 52 and by the provisions on the rights of Government or any
person authorized by the Government as provided in section 84
Section 58A. Acts deemed to be non-infringement.
(1) It shall not be an act of infringement to import, offer for sale, sell or
use—
(a) any patented product; or
(b) any product obtained directly by means of the patented process or
to which the patented process has been applied, which is produced by,
or with the consent, conditional or otherwise, of the owner of the
patent or his licensee.
(2) For the purposes of this section, “patent” includes a patent granted
in any country outside Malaysia in respect of the same or essentially
the same invention as that for which a patent is granted under this Act.